<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C938B173-5DDC-45B5-99C4-2516368FAD32"><gtr:id>C938B173-5DDC-45B5-99C4-2516368FAD32</gtr:id><gtr:name>Public Health England (formerly: Health Protection Agency)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>School of Public Health</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C938B173-5DDC-45B5-99C4-2516368FAD32"><gtr:id>C938B173-5DDC-45B5-99C4-2516368FAD32</gtr:id><gtr:name>Public Health England (formerly: Health Protection Agency)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/295E469F-765E-479A-AE89-336C83C81DDD"><gtr:id>295E469F-765E-479A-AE89-336C83C81DDD</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:surname>Riley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/925A6B0A-3963-42E0-88B6-8686D80BB412"><gtr:id>925A6B0A-3963-42E0-88B6-8686D80BB412</gtr:id><gtr:firstName>Katja</gtr:firstName><gtr:surname>Hoschler</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8F6BB345-AB7C-4995-9342-CE030E22A2D8"><gtr:id>8F6BB345-AB7C-4995-9342-CE030E22A2D8</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>White</gtr:surname><gtr:orcidId>0000-0002-6644-3512</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8E9F49FC-ACAD-47FD-85F9-AFC5FE2CEFBC"><gtr:id>8E9F49FC-ACAD-47FD-85F9-AFC5FE2CEFBC</gtr:id><gtr:firstName>Maria</gtr:firstName><gtr:surname>Zambon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FJ008761%2F1"><gtr:id>ED42330B-C12C-4C4A-B873-F6EEE79E2A17</gtr:id><gtr:title>Understanding herd immunity for influenza using archived sera from the UK and mathematical models</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J008761/1</gtr:grantReference><gtr:abstractText>The 2009 pandemic highlighted some real problems with how scientists and governments monitor influenza. Up-to-now, they have counted numbers of people who go to their doctor or the hospital with flu-like symptoms. But this doesn't tell us about the mild cases.

Mild cases are important because of something called 'herd immunity'. During any epidemic, the number of new cases starts to go down when there are not enough susceptible people to keep 'the fire' of the epidemic going. People with mild or no symptoms are just as good at stopping the epidemic as people with symptoms. So, to be able to understand how big an influenza epidemic might be, we need to measure mild cases as well.

We can do this if we take blood and test for antibodies. In this project, we want to test anonymous blood samples for influenza that were discarded in the late 1990s and early 2000s. By doing 10s of 1000s of tests on these old samples, we can see exactly how useful the data on mild cases might be for future epidemics and we can answer interesting questions about different influenza strains. There were three different types of influenza circulating in the late 1990s and early 2000s. Two types of influenza A and one was influenza B. Two of those three are still circulating now (A/H3N2 and B). One of them was replaced by the pandemic strain (A/H1N1). We want to compare and contract these three types.

We will use mathematical models to analyze the data from the blood tests. Models help us to figure out why an epidemic occurred or was as big as it was, rather than just describing it. We can look at important basic questions like: is flu B less serious infection that influenza A; and if you get a mild infection of flu you can get infected again more quickly than if you get a serious infection?</gtr:abstractText><gtr:technicalSummary>Serological studies of the 2009 pandemic illustrated how patterns of infection were different to patterns of clinical cases. Therefore, standard approaches for the estimation of incidence (e.g. based on surveillance for influenza-like-illness) did not give a clear understanding of how the pool of susceptible individuals is being depleted at any point in time (herd immunity).

In order to fully characterize the transition from Sydney 1997-like to Fujian 2002-like viruses, we will measure the concentration of antibodies in the UK population for both H3 strains for all 6 seasons from 1998/1999 to 2003/2004. Our background knowledge for influenza A H1N1 and B is less complete than for H3N2. Therefore, we focus on a period when both H1N1 and B vaccine strains were changed, 1999-2000 to 2001/2002. To our knowledge, there are no population-wide serological surveys of influenza B.

We will use 3 analytical approaches: 1) we will classify each assay result as either positive or negative based on a titre threshold and then use logistic regression to test interesting hypothesis for the risk of infection; 2), we will incorporate serology as one of a number of data sources to infer parameters for strain-specific healthcare oriented dynamics model; 3) to better understand the relationship between our assay results and; infection, infectivity, susceptibility, and decay; we will propose the most parsimonious transmission model that can represent the full range of assay results and these fundamental processes.

The combination of data and models we propose will allow us to address hypotheses such as: absolute rates of infection with influenza B are lower than those with H3N2 and have a different pattern across age groups; infectivity at intermediate titres is age specific; and the use of pre and post seasonal titres would enable the detection of some strains being more severe than others by allowing the measurements of clinical outcomes against a 'true' measure of infection.</gtr:technicalSummary><gtr:potentialImpactText>This project has been designed to ensure that the scientific discoveries we generate have immediate societal impact. More than half of the existing project team are employed by Health Protection Agency (HPA) and have, as part of their non-project duties, responsibility for the ongoing surveillance and modelling of influenza in the UK. Three of the four new full-time staff to be supported by this project will work for the HPA. When we make discoveries that improve our interpretation of existing data streams or justify additional serological testing, those discoveries will be made by individuals helping to set policy on a day-to-day basis.

Our request for 2 full time postdoctoral modellers and our request for Peter White's time are central to ensuring good impact for this project. By ensuring that the project supports an individual 100% within the HPA modelling unit, we are ensuring the highest possible likelihood that our discoveries will influence ongoing practice and improve influenza policy in the UK. As head of the modelling unit at the HPA, Peter spends a considerable portion of his time explaining the utility of infectious disease dynamics to non-scientists. As a champion for our project, we will ensure that our results are considered at the highest level. 

Elizabeth Miller, Neil Ferguson, Maria Zambon and Steven Riley all sit on key advisory organizations at home and abroad. For example, Prof Miller is a member of the WHO SAGE committee for vaccine preventable diseases, Neil Ferguson was an advisor to the WHO pandemic influenza committee and Maria Zambon is head of the Infection and Immunity function at the health protection agency.

Therefore, because our project is embedded within the UK health policy infrastructure and our senior team is highly engaged with international health policy, we suggest that there is a strong likelihood that our results will have high impact by changing health policy. For example, we expect to demonstrate an immediate value for routine testing of discarded blood samples for currently circulating influenza strains. We will be ideally positioned to champion the adoption of such routine seroepidemiology for influenza in the UK and elsewhere.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-05-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-11-25</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>961146</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Johns Hopkins Bloomberg School of Public Health</gtr:department><gtr:description>FluScape</gtr:description><gtr:id>81D32E19-BC18-413E-802A-1425380CEDC9</gtr:id><gtr:impact>Any paper with Cummings as a co-author.</gtr:impact><gtr:partnerContribution>Johns Hopkins manage the information systems and also conduct mathematical and statistical analysis.</gtr:partnerContribution><gtr:piContribution>We run an epidemiological study in Southern China. At imperial we manage the field site and conduct mathematical and statistical analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England (formerly: Health Protection Agency)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HPRU Modelling</gtr:description><gtr:id>F8DCA773-5C46-4D1B-8A07-11D4E97F44C8</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:partnerContribution>Marc Baguelin (co-I for this MRC grant) is also a theme lead.</gtr:partnerContribution><gtr:piContribution>I am a theme lead for the HPRU in Modelling Methodology held by Neil Ferguson.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England (formerly: Health Protection Agency)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HPRU Respiratory Infections</gtr:description><gtr:id>10E02FE0-68A7-44A0-A5D6-21C78C41EC2E</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:partnerContribution>They will also co supervise staff and helped to write the grant.</gtr:partnerContribution><gtr:piContribution>I am a theme lead for Respiratory infections and will help to supervise staff at Imperial and PHE.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1882747</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The life course of human immune responses to influenza infection and vaccination</gtr:description><gtr:end>2021-04-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>200861/Z/16/Z</gtr:fundingRef><gtr:id>803A7369-DC81-44AF-986A-4959ED611301</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Who Flu Burden</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B32B691D-2EC6-4B14-8A2D-69666D6DE921</gtr:id><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Contact and serological data form Hong Kong</gtr:description><gtr:id>AA3CAEDA-C3F5-465E-9C30-87552F14B6BB</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Hong Kong Flu Contacts</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://rspb.royalsocietypublishing.org/content/281/1789/20140709/suppl/DC1</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97D79441-B856-4A6D-9F3E-F5032AD7097F"><gtr:id>97D79441-B856-4A6D-9F3E-F5032AD7097F</gtr:id><gtr:title>[An international collaborative study on influenza viruses antibody titers and contact patterns of individuals in rural and urban household of Guangzhou].</gtr:title><gtr:parentPublicationTitle>Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8175113ca74119a646bc92f844a3c697"><gtr:id>8175113ca74119a646bc92f844a3c697</gtr:id><gtr:otherNames>Kwok KO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0254-6450</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/201B76D3-9B73-427B-A722-7068910A4AE4"><gtr:id>201B76D3-9B73-427B-A722-7068910A4AE4</gtr:id><gtr:title>Risk factors for severe outcomes among members of the United States military hospitalized with pneumonia and influenza, 2000-2012.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f919f6ab9ec769ab2d5c25bd7250cf7c"><gtr:id>f919f6ab9ec769ab2d5c25bd7250cf7c</gtr:id><gtr:otherNames>Van Kerkhove MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CE2D1343-1E3D-49C0-88A7-1E211F512A03"><gtr:id>CE2D1343-1E3D-49C0-88A7-1E211F512A03</gtr:id><gtr:title>Ebola Virus Disease among Male and Female Persons in West Africa.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cf9080986dd2c4c98653e05a77311da9"><gtr:id>cf9080986dd2c4c98653e05a77311da9</gtr:id><gtr:otherNames>WHO Ebola Response Team</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/213A2099-AE27-44E1-997A-821F234C2E8D"><gtr:id>213A2099-AE27-44E1-997A-821F234C2E8D</gtr:id><gtr:title>Distinguishing Between Reservoir Exposure and Human-to-Human Transmission for Emerging Pathogens Using Case Onset Data.</gtr:title><gtr:parentPublicationTitle>PLoS currents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d089aeea375cacb98e3c9cb5a31eac6b"><gtr:id>d089aeea375cacb98e3c9cb5a31eac6b</gtr:id><gtr:otherNames>Kucharski A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA3404E5-68BF-4FFE-BF50-69FBC3D51E70"><gtr:id>BA3404E5-68BF-4FFE-BF50-69FBC3D51E70</gtr:id><gtr:title>A systematic review of reported reassortant viral lineages of influenza A.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/027454f475c9478478c151d850908532"><gtr:id>027454f475c9478478c151d850908532</gtr:id><gtr:otherNames>Pinsent A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FE24523C-1EB0-417B-AAB6-C6FD927D2874"><gtr:id>FE24523C-1EB0-417B-AAB6-C6FD927D2874</gtr:id><gtr:title>Complex disease dynamics and the design of influenza vaccination programs.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfb5062b3b74deb6e922dc6a4250846e"><gtr:id>bfb5062b3b74deb6e922dc6a4250846e</gtr:id><gtr:otherNames>Riley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/76B0D60B-197A-4DD9-8332-2A5223E2DC73"><gtr:id>76B0D60B-197A-4DD9-8332-2A5223E2DC73</gtr:id><gtr:title>Nine challenges in modelling the emergence of novel pathogens.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd02f721f095349879a24459d0bf5746"><gtr:id>fd02f721f095349879a24459d0bf5746</gtr:id><gtr:otherNames>Lloyd-Smith JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C4B0E5E1-BDD0-4379-BBBE-98E233C3A0C4"><gtr:id>C4B0E5E1-BDD0-4379-BBBE-98E233C3A0C4</gtr:id><gtr:title>Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b13378166d22af7a7ca5b1f192611863"><gtr:id>b13378166d22af7a7ca5b1f192611863</gtr:id><gtr:otherNames>Cauchemez S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C596635F-85D8-4192-BCAC-AC48208F90C1"><gtr:id>C596635F-85D8-4192-BCAC-AC48208F90C1</gtr:id><gtr:title>Unraveling the drivers of MERS-CoV transmission.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b13378166d22af7a7ca5b1f192611863"><gtr:id>b13378166d22af7a7ca5b1f192611863</gtr:id><gtr:otherNames>Cauchemez S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/897311A1-4208-451E-9620-B65D0CBE4CAC"><gtr:id>897311A1-4208-451E-9620-B65D0CBE4CAC</gtr:id><gtr:title>PLOS Currents: Outbreaks --- For findings that the world just can't wait to see.</gtr:title><gtr:parentPublicationTitle>PLoS currents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b9a19e0e5c7baad51cfbe6f289eef2cb"><gtr:id>b9a19e0e5c7baad51cfbe6f289eef2cb</gtr:id><gtr:otherNames>Cowling B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/44D9A3EF-B961-41E7-8F17-4C5104CEC72C"><gtr:id>44D9A3EF-B961-41E7-8F17-4C5104CEC72C</gtr:id><gtr:title>Cohort Profile: A study of influenza immunity in the urban and rural Guangzhou region of China: the Fluscape Study.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cc30a99b64fb741aa217c51f3a645f0e"><gtr:id>cc30a99b64fb741aa217c51f3a645f0e</gtr:id><gtr:otherNames>Jiang CQ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DE43862E-5CF2-4B59-9E7B-2FD92E8F8557"><gtr:id>DE43862E-5CF2-4B59-9E7B-2FD92E8F8557</gtr:id><gtr:title>Viral factors in influenza pandemic risk assessment.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fc51a3c09ef13191fe709f2d522129fc"><gtr:id>fc51a3c09ef13191fe709f2d522129fc</gtr:id><gtr:otherNames>Lipsitch M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2219247D-064C-4120-8934-6B59A120356E"><gtr:id>2219247D-064C-4120-8934-6B59A120356E</gtr:id><gtr:title>Epidemiology: Making high-res Zika maps.</gtr:title><gtr:parentPublicationTitle>Nature microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfb5062b3b74deb6e922dc6a4250846e"><gtr:id>bfb5062b3b74deb6e922dc6a4250846e</gtr:id><gtr:otherNames>Riley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2058-5276</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/93705F01-A8CC-4259-A556-15B3D2B60FBF"><gtr:id>93705F01-A8CC-4259-A556-15B3D2B60FBF</gtr:id><gtr:title>Using quantitative disease dynamics as a tool for guiding response to avian influenza in poultry in the United States of America.</gtr:title><gtr:parentPublicationTitle>Preventive veterinary medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4d60becc2050e924dc5302e034b97bc"><gtr:id>c4d60becc2050e924dc5302e034b97bc</gtr:id><gtr:otherNames>Pepin KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0167-5877</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AB576843-90B4-46E8-9951-F5FFF3EA7E45"><gtr:id>AB576843-90B4-46E8-9951-F5FFF3EA7E45</gtr:id><gtr:title>Intra-Weekly Variations of Influenza-Like Illness in Military Populations.</gtr:title><gtr:parentPublicationTitle>Military medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/08eaa1b927bdf88d6c82651d9afc97a1"><gtr:id>08eaa1b927bdf88d6c82651d9afc97a1</gtr:id><gtr:otherNames>Riley P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0026-4075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB21E230-3B58-4BEC-8FB4-D71850856D52"><gtr:id>CB21E230-3B58-4BEC-8FB4-D71850856D52</gtr:id><gtr:title>Surveillance of low pathogenic novel H7N9 avian influenza in commercial poultry barns: detection of outbreaks and estimation of virus introduction time.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/027454f475c9478478c151d850908532"><gtr:id>027454f475c9478478c151d850908532</gtr:id><gtr:otherNames>Pinsent A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5C553409-266A-46C8-8A15-10760FA631F9"><gtr:id>5C553409-266A-46C8-8A15-10760FA631F9</gtr:id><gtr:title>Inferring infection hazard in wildlife populations by linking data across individual and population scales.</gtr:title><gtr:parentPublicationTitle>Ecology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4d60becc2050e924dc5302e034b97bc"><gtr:id>c4d60becc2050e924dc5302e034b97bc</gtr:id><gtr:otherNames>Pepin KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1461-023X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/37375AA9-2B22-4AAE-A93B-085754A6405B"><gtr:id>37375AA9-2B22-4AAE-A93B-085754A6405B</gtr:id><gtr:title>Cardiac Safety Research Consortium: can the thorough QT/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward.</gtr:title><gtr:parentPublicationTitle>American heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/89630e6ad3a75d5a90e353e9013fb7ef"><gtr:id>89630e6ad3a75d5a90e353e9013fb7ef</gtr:id><gtr:otherNames>Darpo B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-8703</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8A17B1B3-781D-4CBA-85F0-C0360DCACFE2"><gtr:id>8A17B1B3-781D-4CBA-85F0-C0360DCACFE2</gtr:id><gtr:title>Transmission Potential of Influenza A(H7N9) Virus, China, 2013-2014.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f741f76c2b1d78183e956abc23d9da33"><gtr:id>f741f76c2b1d78183e956abc23d9da33</gtr:id><gtr:otherNames>Kucharski AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8B3CBD08-A48C-4208-B16A-20222DE5A477"><gtr:id>8B3CBD08-A48C-4208-B16A-20222DE5A477</gtr:id><gtr:title>Social mixing patterns in rural and urban areas of southern China.</gtr:title><gtr:parentPublicationTitle>Proceedings. Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/84337833d8b63ad1be8a59ca8f98e55c"><gtr:id>84337833d8b63ad1be8a59ca8f98e55c</gtr:id><gtr:otherNames>Read JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-8452</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1D250AE4-D397-43C8-BADC-C7A1ED0B18D6"><gtr:id>1D250AE4-D397-43C8-BADC-C7A1ED0B18D6</gtr:id><gtr:title>Five challenges for stochastic epidemic models involving global transmission.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/83a1f2f4aab80e7e78ee2e09ffc84192"><gtr:id>83a1f2f4aab80e7e78ee2e09ffc84192</gtr:id><gtr:otherNames>Britton T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D13F8E47-FC90-410C-8E41-8C5032B31941"><gtr:id>D13F8E47-FC90-410C-8E41-8C5032B31941</gtr:id><gtr:title>A comparison of hemagglutination inhibition and neutralization assays for characterizing immunity to seasonal influenza A.</gtr:title><gtr:parentPublicationTitle>Influenza and other respiratory viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/491924ace0ecf31308a6eb721fd5891a"><gtr:id>491924ace0ecf31308a6eb721fd5891a</gtr:id><gtr:otherNames>Truelove S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1750-2640</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D60C96BA-CC1E-41DE-B1DC-9C6941904E8A"><gtr:id>D60C96BA-CC1E-41DE-B1DC-9C6941904E8A</gtr:id><gtr:title>CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.</gtr:title><gtr:parentPublicationTitle>Influenza and other respiratory viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9197fe3e8aa06f6492a33bc787b3f786"><gtr:id>9197fe3e8aa06f6492a33bc787b3f786</gtr:id><gtr:otherNames>Horby PW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1750-2640</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/20E5BF16-CF77-4AEA-B20B-19F01C517388"><gtr:id>20E5BF16-CF77-4AEA-B20B-19F01C517388</gtr:id><gtr:title>Minimizing the threat of pandemic emergence from avian influenza in poultry systems.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4d60becc2050e924dc5302e034b97bc"><gtr:id>c4d60becc2050e924dc5302e034b97bc</gtr:id><gtr:otherNames>Pepin KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/913458FB-DD8C-4A2B-93B1-E0C24CBD7440"><gtr:id>913458FB-DD8C-4A2B-93B1-E0C24CBD7440</gtr:id><gtr:title>Six challenges in measuring contact networks for use in modelling.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d5a6dd9d53a7c1b95463407fb940380"><gtr:id>7d5a6dd9d53a7c1b95463407fb940380</gtr:id><gtr:otherNames>Eames K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52A92F57-E633-42B1-BEE8-197699D5F4B7"><gtr:id>52A92F57-E633-42B1-BEE8-197699D5F4B7</gtr:id><gtr:title>The contribution of social behaviour to the transmission of influenza A in a human population.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f741f76c2b1d78183e956abc23d9da33"><gtr:id>f741f76c2b1d78183e956abc23d9da33</gtr:id><gtr:otherNames>Kucharski AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB282CBD-180D-4D79-B8C1-8F96B87FCEAA"><gtr:id>FB282CBD-180D-4D79-B8C1-8F96B87FCEAA</gtr:id><gtr:title>Exposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational Study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/63906b01248a2d2c2c6b91dad43ada70"><gtr:id>63906b01248a2d2c2c6b91dad43ada70</gtr:id><gtr:otherNames>International Ebola Response Team</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/78CDFDEA-684D-4E3E-AD59-8F33D837E9A6"><gtr:id>78CDFDEA-684D-4E3E-AD59-8F33D837E9A6</gtr:id><gtr:title>Anticipating the prevalence of avian influenza subtypes H9 and H5 in live-bird markets.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4d60becc2050e924dc5302e034b97bc"><gtr:id>c4d60becc2050e924dc5302e034b97bc</gtr:id><gtr:otherNames>Pepin KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/80060237-AFAE-442F-A28E-B03F2FC80D79"><gtr:id>80060237-AFAE-442F-A28E-B03F2FC80D79</gtr:id><gtr:title>Global circulation patterns of seasonal influenza viruses vary with antigenic drift.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/71fafd4a0e8082523ed381695139b36e"><gtr:id>71fafd4a0e8082523ed381695139b36e</gtr:id><gtr:otherNames>Bedford T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52A448A9-DDA2-4E5C-ABF1-BB95910AC3B4"><gtr:id>52A448A9-DDA2-4E5C-ABF1-BB95910AC3B4</gtr:id><gtr:title>Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f741f76c2b1d78183e956abc23d9da33"><gtr:id>f741f76c2b1d78183e956abc23d9da33</gtr:id><gtr:otherNames>Kucharski AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3E51794-485A-4D8E-8EDC-5F6CB6EFD1B0"><gtr:id>B3E51794-485A-4D8E-8EDC-5F6CB6EFD1B0</gtr:id><gtr:title>Social contacts and the locations in which they occur as risk factors for influenza infection.</gtr:title><gtr:parentPublicationTitle>Proceedings. Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8175113ca74119a646bc92f844a3c697"><gtr:id>8175113ca74119a646bc92f844a3c697</gtr:id><gtr:otherNames>Kwok KO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-8452</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A96D6F5E-8879-4D02-AF4C-33D01AB615CD"><gtr:id>A96D6F5E-8879-4D02-AF4C-33D01AB615CD</gtr:id><gtr:title>Simulation-guided design of serological surveys of the cumulative incidence of influenza infection.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0fd3052f675ab3b1cce65819ff641463"><gtr:id>0fd3052f675ab3b1cce65819ff641463</gtr:id><gtr:otherNames>Wu KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1F67DA72-A3B2-4937-9A49-A82500DDB161"><gtr:id>1F67DA72-A3B2-4937-9A49-A82500DDB161</gtr:id><gtr:title>Reducing uncertainty about flavivirus infections.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d089aeea375cacb98e3c9cb5a31eac6b"><gtr:id>d089aeea375cacb98e3c9cb5a31eac6b</gtr:id><gtr:otherNames>Kucharski A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4728D153-C579-4B36-AA35-AADD816341F0"><gtr:id>4728D153-C579-4B36-AA35-AADD816341F0</gtr:id><gtr:title>Phylogenetic evidence for a mild H1 pandemic in the early 1900s.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfb5062b3b74deb6e922dc6a4250846e"><gtr:id>bfb5062b3b74deb6e922dc6a4250846e</gtr:id><gtr:otherNames>Riley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E07577BB-7EED-410A-B195-556A9F9282A8"><gtr:id>E07577BB-7EED-410A-B195-556A9F9282A8</gtr:id><gtr:title>Estimation of the Basic Reproductive Number and Mean Serial Interval of a Novel Pathogen in a Small, Well-Observed Discrete Population.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0fd3052f675ab3b1cce65819ff641463"><gtr:id>0fd3052f675ab3b1cce65819ff641463</gtr:id><gtr:otherNames>Wu KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E2B2836F-E41D-4234-B57A-5962F9CEBB43"><gtr:id>E2B2836F-E41D-4234-B57A-5962F9CEBB43</gtr:id><gtr:title>Spatial and temporal dynamics of superspreading events in the 2014-2015 West Africa Ebola epidemic.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e85c8c567beb1393c1fa53490e2fd8b5"><gtr:id>e85c8c567beb1393c1fa53490e2fd8b5</gtr:id><gtr:otherNames>Lau MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/49265F4A-45F7-4F59-88A8-F132DEB54CC5"><gtr:id>49265F4A-45F7-4F59-88A8-F132DEB54CC5</gtr:id><gtr:title>Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fc51a3c09ef13191fe709f2d522129fc"><gtr:id>fc51a3c09ef13191fe709f2d522129fc</gtr:id><gtr:otherNames>Lipsitch M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5C558EED-56F1-425A-802E-6C5F58CCD714"><gtr:id>5C558EED-56F1-425A-802E-6C5F58CCD714</gtr:id><gtr:title>Early real-time estimation of the basic reproduction number of emerging or reemerging infectious diseases in a community with heterogeneous contact pattern: Using data from Hong Kong 2009 H1N1 Pandemic Influenza as an illustrative example.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8175113ca74119a646bc92f844a3c697"><gtr:id>8175113ca74119a646bc92f844a3c697</gtr:id><gtr:otherNames>Kwok KO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E56C14B0-33B3-4B47-A4F5-D640567C95CF"><gtr:id>E56C14B0-33B3-4B47-A4F5-D640567C95CF</gtr:id><gtr:title>Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart.</gtr:title><gtr:parentPublicationTitle>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b13378166d22af7a7ca5b1f192611863"><gtr:id>b13378166d22af7a7ca5b1f192611863</gtr:id><gtr:otherNames>Cauchemez S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1025-496X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/62E6C7A3-B063-4088-AA58-07C35CBFA949"><gtr:id>62E6C7A3-B063-4088-AA58-07C35CBFA949</gtr:id><gtr:title>After Ebola in West Africa--Unpredictable Risks, Preventable Epidemics.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cf9080986dd2c4c98653e05a77311da9"><gtr:id>cf9080986dd2c4c98653e05a77311da9</gtr:id><gtr:otherNames>WHO Ebola Response Team</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/63E36F86-AE15-4E01-9C5D-0DBB368113C1"><gtr:id>63E36F86-AE15-4E01-9C5D-0DBB368113C1</gtr:id><gtr:title>The spatial resolution of epidemic peaks.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/531e490605bdca10c1b955f966b3cfd1"><gtr:id>531e490605bdca10c1b955f966b3cfd1</gtr:id><gtr:otherNames>Mills HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/319AD1F8-F1C4-4DEA-B8E1-EECDDA285528"><gtr:id>319AD1F8-F1C4-4DEA-B8E1-EECDDA285528</gtr:id><gtr:title>Improving pandemic influenza risk assessment.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b0b8e1725c014c1320e991217b4813eb"><gtr:id>b0b8e1725c014c1320e991217b4813eb</gtr:id><gtr:otherNames>Russell CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F09986F4-D867-46F5-85B5-78344BFB81D2"><gtr:id>F09986F4-D867-46F5-85B5-78344BFB81D2</gtr:id><gtr:title>Five challenges for spatial epidemic models.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfb5062b3b74deb6e922dc6a4250846e"><gtr:id>bfb5062b3b74deb6e922dc6a4250846e</gtr:id><gtr:otherNames>Riley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J008761/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>